PACB vs. SPY
Compare and contrast key facts about Pacific Biosciences of California, Inc. (PACB) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PACB or SPY.
Correlation
The correlation between PACB and SPY is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PACB vs. SPY - Performance Comparison
Key characteristics
PACB:
-0.54
SPY:
0.32
PACB:
-0.34
SPY:
0.51
PACB:
0.96
SPY:
1.07
PACB:
-0.67
SPY:
0.39
PACB:
-1.25
SPY:
1.52
PACB:
52.29%
SPY:
3.13%
PACB:
120.29%
SPY:
14.74%
PACB:
-97.79%
SPY:
-55.19%
PACB:
-97.67%
SPY:
-12.17%
Returns By Period
In the year-to-date period, PACB achieves a -34.97% return, which is significantly lower than SPY's -8.15% return. Over the past 10 years, PACB has underperformed SPY with an annualized return of -14.75%, while SPY has yielded a comparatively higher 11.89% annualized return.
PACB
-34.97%
-11.85%
-26.99%
-64.58%
-14.84%
-14.75%
SPY
-8.15%
-6.68%
-4.88%
4.64%
18.45%
11.89%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PACB vs. SPY — Risk-Adjusted Performance Rank
PACB
SPY
PACB vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Pacific Biosciences of California, Inc. (PACB) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PACB vs. SPY - Dividend Comparison
PACB has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.34%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PACB Pacific Biosciences of California, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.34% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
PACB vs. SPY - Drawdown Comparison
The maximum PACB drawdown since its inception was -97.79%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for PACB and SPY. For additional features, visit the drawdowns tool.
Volatility
PACB vs. SPY - Volatility Comparison
Pacific Biosciences of California, Inc. (PACB) has a higher volatility of 21.41% compared to SPDR S&P 500 ETF (SPY) at 7.47%. This indicates that PACB's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.